This is the authors' abstract. We don't add key points for this paper.
Subnormal testosterone concentrations have been found in 25% of men with type 2 diabetes in association with inappropriately low luteinizing hormone and follicle-stimulating hormone concentrations (1), which suggests that the primary defect may be at the hypothalamo-hypophyseal level. Circulating anti-pituitary antibodies (APAs) were first detected by Kobayashi et al. (2) in sera from 91 patients with type 2 diabetes at a relatively high frequency (24.2%). Thus far, a possible role of pituitary autoimmunity in diabetic patients with hypogonadotropic hypogonadism (HH) has never been investigated. Ninety-five consecutive male patients with type 2 diabetes and aged >35 years were recruited among those attending the Unit of Endocrinology and Metabolic Diseases at the Second University of Naples from September 2010 to September 2012. Patients with severe obesity (BMI >35 kg/m2) were excluded. The diagnosis of isolated HH included a serum testosterone level <12.0 nmol/L, normal or low gonadotropin concentrations, and symptoms and signs of androgen deficiency.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Bellastella et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: